Paper Details

  1. Home
  2. Paper Details

Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study.

Author: CunninghamJanet L, LannergårdAnders, RamklintMia, SundbergIsak

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Observational StudyResearch that observes and collects data on participants' behavior and outcomes in their natural state, without intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study aimed to investigate psychiatric side effects, including depressive symptoms and sleep disturbances, of new interferon-free treatments for Hepatitis C virus (HCV) infection in real-world patients, including those with a history of psychiatric diagnosis or substance abuse.
Paper Details　
Original Abstract of the Article :
Treatment of Hepatitis C virus (HCV) infection has evolved from interferon (IFN)-based treatments to direct-acting antivirals (DAAs). Patients with HCV have an elevated psychiatric morbidity (including substance abuse) and patients with such comorbidity have often been excluded from treatment with I...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975521/

データ提供：米国国立医学図書館（NLM）

Direct-Acting Antivirals for Hepatitis C: A New Oasis in the Desert of Treatment

Hepatitis C is a disease that often feels like a desert – desolate, harsh, and potentially debilitating. This study delves into the psychiatric side effects of new, interferon-free treatments for HCV, specifically direct-acting antivirals (DAAs), which have emerged as a ray of hope in the treatment landscape.

Navigating the Psychiatric Landscape

The researchers found that these new DAAs were not associated with psychiatric side effects, even in patients with a history of psychiatric diagnosis or substance abuse. This is like finding a pathway through the desert that leads to a tranquil oasis, free from the harsh elements of psychiatric complications.

A Path Towards Better Treatment

The study offers encouraging news for patients with HCV, suggesting that DAAs provide a safe and effective way to combat the disease without the added burden of psychiatric side effects. This is a significant step forward in the journey towards better treatment and improved outcomes for patients.

Dr. Camel's Conclusion

This study offers a glimmer of hope in the desert of HCV treatment. By minimizing the risk of psychiatric side effects, DAAs offer a path towards better management and a potentially brighter future for patients.
Date :
  1. Date Completed 2019-03-01
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

29843679

DOI: Digital Object Identifier

PMC5975521

Related Literature

Article Analysis
・Side Effects of daclatasvir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.